Six ways I-MAK is lying about biopharma patents
TheArnold-Venture funded advocacy group Initiative for Medicines, Access& Knowledge, Inc. (or I-MAK) is on a global media tour, espousing their point of view on the patent system. Someexperts and congressional leaders don ’t buy the rhetoric, and neither should you. Here are the top myths to look out for:
Source: The Catalyst - Category: Pharmaceuticals Authors: Megan Van Etten Tags: Patents Intellectual Property Source Type: news
More News: Pharmaceuticals | Politics